Anna Fabisiewicz
Overview
Explore the profile of Anna Fabisiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szostakowska-Rodzos M, Grzybowska E, Mysliwy I, Zub R, Jagiello-Gruszfeld A, Rubach M, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076662
Monitoring of metastatic breast cancer (mBC) is an important issue in the clinical management of patients. Liquid biopsy has become a non-invasive method for detecting and monitoring cancer in body...
2.
Szostakowska-Rodzos M, Chmielarczyk M, Zacharska W, Fabisiewicz A, Kurzyk A, Mysliwy I, et al.
Bioengineering (Basel)
. 2025 Feb;
12(2).
PMID: 40001667
The majority of the current cancer research is based on two-dimensional cell cultures and animal models. These methods have limitations, including different expressions of key factors involved in carcinogenesis and...
3.
Fabisiewicz A, Szostakowska-Rodzos M, Grzybowska E
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408942
Circulating tumor cell (CTC) numbers in the blood of cancer patients can indicate the progression and invasiveness of tumors, and their prognostic and predictive value has been repeatedly demonstrated. However,...
4.
Szostakowska-Rodzos M, Fabisiewicz A, Wakula M, Tabor S, Szafron L, Jagiello-Gruszfeld A, et al.
Sci Rep
. 2024 Jun;
14(1):12924.
PMID: 38839863
Hormone-responsive breast cancer represents the most common type and has the best prognosis, but still approximately 40% of patients with this type can develop distant metastases, dramatically worsening the patient's...
5.
Mossakowska B, Fabisiewicz A, Tudek B, Siedlecki J
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499013
Photodynamic therapy (PDT) is a low-invasive treatment method that can be used to treat VIN patients. A photosensitizer (PS) applied to a patient is activated with use of the appropriate...
6.
Mossakowska B, Shahmoradi Ghahe S, Cysewski D, Fabisiewicz A, Tudek B, Siedlecki J
Int J Mol Sci
. 2022 Apr;
23(8).
PMID: 35456936
Photodynamic therapy (PDT) is a valuable treatment method for vulvar intraepithelial neoplasia (VIN). It allows for the treatment of a multifocal disease with minimal tissue destruction. 5-Aminolevulinic acid (5-ALA) is...
7.
Mossakowska B, Fabisiewicz A, Siedlecki J
Postepy Biochem
. 2021 Dec;
67(3):236-247.
PMID: 34894388
Photodynamic therapy (PDT) is one of the least toxic methods causing the death of cancer cells. Photosensitizer (PS) applied to a patient accumulates in the tumor, where under the appropriate...
8.
Tabor S, Szostakowska-Rodzos M, Fabisiewicz A, Grzybowska E
Int J Mol Sci
. 2020 Nov;
21(21).
PMID: 33182512
Breast cancer metastasis is the main cause of breast cancer mortality. Luminal breast cancer represents the majority of breast cancer cases and, despite relatively good prognosis, its heterogeneity creates problems...
9.
Fabisiewicz A, Szostakowska-Rodzos M, Zaczek A, Grzybowska E
Int J Mol Sci
. 2020 Mar;
21(5).
PMID: 32121386
Breast cancer metastasis is the leading cause of cancer deaths in women and is difficult to combat due to the long periods in which disseminated cells retain a potential to...
10.
Szostakowska M, Trebinska-Stryjewska A, Grzybowska E, Fabisiewicz A
Breast Cancer Res Treat
. 2018 Nov;
173(3):489-497.
PMID: 30382472
Introduction: The majority of breast cancers (BCs) are characterized by the expression of estrogen receptor alpha (ERα+). ERα acts as ligand-dependent transcription factor for genes associated with cell survival, proliferation,...